Anne Kiltie who has been awarded the title of Professor of Experimental Clinical Oncology.
Geoff Higgins, Somnath Mukherjee, Wojciech Niedzwiedz and Andrew Protheroe who have all been awarded Associate Professorships.
Bart Conelissen on becoming a University Research Lecturer.
An Oxford researcher has been awarded almost £1m from Cancer Research UK to investigate a new form of treatment for prostate cancer.
Ricky Sharma, Group Leader at the CRUK/MRC Oxford Institute for Radiation Oncology and the Department of Oncology, has been appointed to the position of Professor and Chair of Radiation Oncology at University College London. He will start in his new post in July.
Professor Tim Maughan, from the CRUK/MRC Oxford Institute for Radiation Oncology, has been named among the eight medical researchers at Oxford University who have been elected as Fellows of the Academy of Medical Sciences. The honour recognises outstanding contribution to the advancement of medical science, innovative application of scientific knowledge, or conspicuous service to healthcare.
Oxford scientists will play a key role in ground-breaking research into new radiotherapy and immunotherapy treatments for cancer patients following a multi-million pound investment.
Researchers from the city’s Cancer Research UK Centre will be collaborating with scientists across the UK, following the announcement today of the charity’s Centres’ Network Accelerator Awards.
Designed to inspire new approaches to beating cancer, the awards will invest around £16 million UK-wide over the next five years.
Pancreatic Cancer Research Fund (PCRF) is funding six new research projects with a total of £1 million - bringing the charity’s support for research into the UK’s most lethal cancer to over £8 million. This is the third year that PCRF has invested £1 million in a single funding round. In total, the charity has funded 40 cutting edge research projects across the UK and Ireland, worth over £6 million.
An Oxford cancer patient who was told she may have only eighteen months to live is free from signs of the disease after taking a trial drug for almost three years. Susan Cakebread received her pioneering treatment at the Early Phase Clinical Trials Unit at Oxford’s Churchill Hospital which aims to discover new treatments for the future.
Dr Sarah Blagden, Associate Professor of Experimental Cancer Therapeutics in the Department of Oncology, has become the Experimental Cancer Medicine Centre (ECMC) lead for Oxford.
Roche has awarded four Early Stage Researchers the Roche Discovery Oncology Award at its Innovation Center in Penzberg near Munich.